Sibling history is associated with heart failure after a first myocardial infarction.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
2020
Historique:
received: 26 07 2019
revised: 20 11 2019
accepted: 26 11 2019
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 1 7 2020
Statut: epublish

Résumé

Morbidity and mortality due to heart failure (HF) as a complication of myocardial infarction (MI) is high, and remains among the leading causes of death and hospitalisation. This study investigated the association between family history of MI with or without HF, and the risk of developing HF after first MI. Through nationwide registries, we identified all individuals aged 18-50 years hospitalised with first MI from 1997 to 2016 in Denmark. We identified 13 810 patients with MI, and the cohort was followed until HF diagnosis, second MI, 3 years after index MI, emigration, death or the end of 2016, whichever occurred first. HRs were estimated by Cox hazard regression models adjusted for sex, age, calendar year and comorbidities (reference: patients with no family history of MI). After adjustment, we observed an increased risk of MI-induced HF for those having a sibling with MI with HF (HR 2.05, 95% CI 1.02 to 4.12). Those having a sibling with MI without HF also had a significant, but lower increased risk of HF (HR 1.39, 95% CI 1.05 to 1.84). Parental history of MI with or without HF was not associated with HF. In this nationwide cohort, sibling history of MI with or without HF was associated with increased risk of HF after first MI, while a parental family history was not, suggesting that shared environmental factors may predominate in the determination of risk for developing HF.

Identifiants

pubmed: 32257244
doi: 10.1136/openhrt-2019-001143
pii: openhrt-2019-001143
pmc: PMC7103809
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e001143

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Open Heart. 2017 Dec 22;4(2):e000551
pubmed: 29296283
Cardiovasc Res. 2018 Jul 15;114(9):1241-1257
pubmed: 29617720
N Engl J Med. 2006 Jul 13;355(2):138-47
pubmed: 16837677
Eur J Heart Fail. 2008 Jul;10(7):658-60
pubmed: 18539522
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
Nat Genet. 2017 Mar;49(3):403-415
pubmed: 28135244
Ann Epidemiol. 1996 May;6(3):188-94
pubmed: 8827153
Nat Genet. 2018 Sep;50(9):1225-1233
pubmed: 29892015
Circulation. 2018 Mar 20;137(12):1290-1292
pubmed: 29555712
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Ann Epidemiol. 2001 Nov;11(8):522-8
pubmed: 11709270
JACC Cardiovasc Imaging. 2018 Jan;11(1):1-11
pubmed: 28917679
Int J Cardiol. 2016 Nov 15;223:379-384
pubmed: 27543714
Br Heart J. 1979 Oct;42(4):373-80
pubmed: 508467
Nat Genet. 2018 Sep;50(9):1234-1239
pubmed: 30061737
JAMA Cardiol. 2018 Aug 1;3(8):703-710
pubmed: 29998296
JAMA. 2005 Dec 28;294(24):3117-23
pubmed: 16380592
Basic Clin Pharmacol Toxicol. 2016 Oct;119(4):376-80
pubmed: 27098169
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Lancet. 2017 Oct 28;390(10106):1981-1995
pubmed: 28460827
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Nat Genet. 2018 Nov;50(11):1505-1513
pubmed: 30297969
Eur Heart J. 2008 Mar;29(6):748-56
pubmed: 18308687
Eur Heart J. 2015 Oct 21;36(40):2674-6
pubmed: 26788565
Circ Cardiovasc Genet. 2010 Jun;3(3):256-66
pubmed: 20445134
JAMA Cardiol. 2016 May 1;1(2):156-62
pubmed: 27437886
Sci Rep. 2017 Jun 5;7(1):2761
pubmed: 28584231
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Circulation. 2016 Dec 6;134(23):e535-e578
pubmed: 27799274

Auteurs

Charlotte Glinge (C)

Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

Louise Oestergaard (L)

Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark.

Reza Jabbari (R)

Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Sara Rossetti (S)

Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Regitze Skals (R)

Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark.

Lars Køber (L)

Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Thomas Engstrøm (T)

Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Cardiology, University of Lund, Lund, Sweden.

Connie R Bezzina (CR)

Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

Christian Torp-Pedersen (C)

Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark.

Gunnar Gislason (G)

Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
The Danish Heart Foundation, Copenhagen, Denmark.

Jacob Tfelt-Hansen (J)

Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH